Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis

NCT04639271 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-positive Breast Cancer

Interventions

DRUG: Pyrotinib Plus And
DRUG: Trastuzumab
DRUG: Abraxane

Sponsor

Shandong Cancer Hospital and Institute